NWL
57
3
UAL
67
-2
BA
39
3
EXPD
61
2
MA
64
4
AON
56
4
HCP
70
4
CVX
40
8
OXY
40
4
SCHW
49
4
HIG
70
2
AA
61
-2
WEC
45
2
QCOM
57
-2
BXP
59
2
DE
56
3
PRGO
39
2
MUR
48
4
NWSA
58
4
AMAT
59
-5
NWL
57
3
UAL
67
-2
BA
39
3
EXPD
61
2
MA
64
4
AON
56
4
HCP
70
4
CVX
40
8
OXY
40
4
SCHW
49
4
HIG
70
2
AA
61
-2
WEC
45
2
QCOM
57
-2
BXP
59
2
DE
56
3
PRGO
39
2
MUR
48
4
NWSA
58
4
AMAT
59
-5
Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
48

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
14.98
Seasonality Move:
-6.82%
Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
275.08
Seasonality Move:
4.48%
Sell
48
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $15.21. The Score for BIS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $15.21
    The current trend is relatively stagnant and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $274.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 54.24 Buy
Chaikin Money Flow: 5878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.43 - 15.21) Buy
Bollinger Bands (100): (14.7 - 17.24) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.58 Buy
Relative Strength Index (14 RSI): 58.54 Buy
Chaikin Money Flow: 227264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.28 - 277.8) Buy
Bollinger Bands (100): (173.47 - 275.75) Buy

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.96 Buy
20-day SMA: 14.92 Buy
50-day SMA: 14.99 Buy
200-day SMA: 17.14 Sell
8-day EMA: 15.07 Buy
20-day EMA: 14.95 Buy
50-day EMA: 15.2 Buy
200-day EMA: 17.17 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 273.53 Buy
20-day SMA: 264.94 Buy
50-day SMA: 262.48 Buy
200-day SMA: 194.67 Buy
8-day EMA: 272.54 Buy
20-day EMA: 269.21 Buy
50-day EMA: 257.72 Buy
200-day EMA: 211.82 Buy

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):